Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Clonmel (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan medoxil blocks the angiotensin II type‑1 receptor, preventing the hormone from causing vasoconstriction and aldosterone release. This results in relaxed blood vessels and reduced sodium‑water retention, contributing to overall blood‑pressure reduction when paired with amlodipine and hydrochlorothiazide.

The prescribed dose is determined by the treating physician based on the patient’s blood‑pressure goals, renal function, and tolerance. Dosage adjustments are made individually; patients should follow the prescriber’s instructions and not alter the regimen without medical advice.

Olmesartan Medoxil/Amlodipine/Hydrochlorothiazide is contraindicated in pregnancy because angiotensin‑II receptor blockers can cause fetal toxicity. Breastfeeding is not recommended as the components may pass into milk and affect the infant. Alternative therapies should be considered for pregnant or lactating patients.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑agent therapy, the triple‑component tablet offers broader blood‑pressure control by targeting three pathways simultaneously, often reducing the need for multiple pills. It is generally more convenient than prescribing separate ARB, calcium‑channel blocker and diuretic tablets, though individual tolerability and cost may influence choice.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture, heat and direct sunlight, and ensure the packaging remains sealed until use.

The medication is taken orally, usually once daily, with or without food. Patients should swallow the tablet whole with a full glass of water and avoid crushing or chewing it unless specifically instructed by a healthcare professional.

Serious adverse events include severe hypotension, acute kidney injury, hyperkalemia, angio‑edema and significant electrolyte disturbances. Prompt medical attention is required if symptoms such as fainting, swelling of the face or throat, rapid weight gain, or muscle weakness occur.

The combination is contraindicated in patients with known hypersensitivity to any component, severe renal impairment, hyperkalemia, or those who are pregnant. Caution is also advised for individuals with aortic stenosis, hepatic disease, or who are taking interacting medications without proper monitoring.